Product Surveillance Registry

Recruiting now

Conditions studied: Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders, Digestive Disorders, Intracranial Aneurysm, Mechanical Circulatory Support, Respiratory Therapy, Aortic, Peripheral Vascular and Venous Disorders, Minimally Invasive Surgical Procedures, Diagnostic Techniques and Procedures, Surgical Procedures, Operative, Renal Insufficiency, Neurovascular, Coronary Artery Disease, Ear, Nose and Throat Disorder

In brief

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.

Key facts

Study ID

NCT01524276

Run by

Medtronic

People needed

100000

Starts

2012-01-01

Expected to finish

2040-01-01

Last updated by the study team

2026-07-17

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
• Patient has or is intended to receive or be treated with an eligible Medtronic product
• Patient within enrollment window relative to therapy initiation or meets criteria for retrospective enrollment

You may not qualify if…

• Patient who is, or will be, inaccessible for follow-up
• Patient with exclusion criteria required by local law
• Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results

Where it is running

• Study site — Huntsville, Alabama, United States (enrolling)
• Study site — Chandler, Arizona, United States (enrolling)
• Study site — Phoenix, Arizona, United States (enrolling)
• Study site — Little Rock, Arkansas, United States (enrolling)
• Study site — Aliso Viejo, California, United States (enrolling)
• Study site — Chula Vista, California, United States (enrolling)
• Study site — Colton, California, United States (enrolling)
• Study site — La Jolla, California, United States (enrolling)
• Study site — Los Angeles, California, United States (enrolling)
• Study site — Napa, California, United States (enrolling)
• Study site — Redwood City, California, United States (enrolling)
• Study site — Salinas, California, United States (enrolling)
• Study site — San Diego, California, United States (enrolling)
• Study site — Stanford, California, United States (enrolling)
• Study site — Torrance, California, United States (enrolling)
• Study site — Ventura, California, United States (enrolling)
• Study site — Aurora, Colorado, United States (enrolling)
• Study site — Colorado Springs, Colorado, United States (enrolling)
• Study site — Lakewood, Colorado, United States (enrolling)
• Study site — Darien, Connecticut, United States (enrolling)
• Study site — Hartford, Connecticut, United States (enrolling)
• Study site — New Haven, Connecticut, United States (enrolling)
• Study site — Washington D.C., District of Columbia, United States (enrolling)
• Study site — Bradenton, Florida, United States (enrolling)
• Study site — Birmingham, Alabama, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.